Enabling the Delivery of Next-Generation Therapeutics
Suono Bio is developing breakthrough technology to potentially enable ultra-rapid delivery of therapeutics and macromolecules, across tissues, including the gastrointestinal (GI) tract. Preclinical studies have demonstrated the capacity to deliver small molecules, proteins, and nucleic acids locally and systemically, validating further development of the system. Designed as an easy-to-use device to enable patients to self-administer medication at home, the SuonoCalm technology may also be applicable to a broad set of conditions outside of the GI tract. The proprietary technology, born from the research laboratories at MIT, aims to provide a vastly improved drug delivery system.
COVERAGE OF OUR WORK
See all of our news
The Leadership Team